Page
%P
-
Article
Open AccessmTOR inhibitor reduces nontumour-related death in liver transplantation for hepatocellular carcinoma
Sirolimus is a regularly applied immunosuppressant for patients undergoing liver transplantation (LT) for hepatocellular carcinoma (HCC). Sirolimus not only significantly inhibits HCC recurrence but also prote...
-
Article
Open AccessThe predictive value of the modified AFP model for liver transplantation outcomes in multinodular hepatocellular carcinoma patients
There is a lack of studies focusing on the benefit of liver transplantation (LT) in hepatocellular carcinoma (HCC) patients with > 3 tumors. This study aims to establish a model to effectively predict overall ...